Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis

Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis

ESRD patients receiving hemodialysis (HD) were excluded from landmark trials evaluating direct-acting oral anticoagulants (DOACs) in atrial fibrillation (AF). The objective was to evaluate prescribing and bleeding with DOACs compared to warfarin in AF patients with chronic HD. A retrospective, obser...

Full description

Bibliographic Details
Main Authors: Estella Davis, Dallin Darais, Kevin Fuji, Paige Nekola, Khalid Bashir
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Pharmacy
Subjects:
end-stage renal disease
esrd
eskd
hemodialysis
hd
direct oral anticoagulation
doacs
atrial fibrillation
af
Online Access:https://www.mdpi.com/2226-4787/8/1/37

Internet

https://www.mdpi.com/2226-4787/8/1/37

Similar Items